Synapse - Urvi A Shah

Urvi A Shah

Groups

Hematologic Malignancies, Division of
Department of Medicine
CTCR Scholars

Research Focus

Medicine; Assistant Attending

https://orcid.org/0000-0001-8419-1091

20086

Recent additions – View all

Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
Journal Article

Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save
Evaluating serum free light chain ratio as a biomarker in multiple myeloma
Journal Article

Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
Haematologica (2025)

Fulltext@MSK | Save
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): Results from a randomised, open-label, phase 3 trial
Journal Article

Mina, R.; Mylin, A. K.; Yokoyama, H.; Magen, H.; Alsdorf, W.; Minnema, M. C.; Shune, L.; Isufi, I.; Harrison, S. J.; Shah, U. A.; more...
The Lancet Haematology (2025)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications

Blood (66)
Clinical Lymphoma, Myeloma and Leukemia (42)
Journal of Clinical Oncology (15)
Blood Cancer Journal (8)
Blood Advances (6)
Biology of Blood and Marrow Transplantation (4)
Leukemia and Lymphoma (4)
Leukemia (4)
American Journal of Hematology (3)
Haematologica (3)